These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33077651)

  • 21. Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019.
    Huband MD; Thompson JD; Gurung ND; Liu Q; Li L; Zhang J; Streit JM; Castanheira M
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0139721. PubMed ID: 34633850
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Huband MD; Mendes RE; Pfaller MA; Lindley JM; Strand GJ; Benn VJ; Zhang J; Li L; Zhang M; Tan X; Liu Q; Flamm RK
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071042
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Pfaller MA; Li L; Liu Q; Zhang J; Huband MD; Lindley JM; Mendes RE
    JAC Antimicrob Resist; 2021 Dec; 3(4):dlab177. PubMed ID: 34917942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
    Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.
    Castanheira M; Mendes RE; Jones RN; Sader HS
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4770-7. PubMed ID: 27216075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea.
    Jung Y; Lee SS; Song W; Kim HS; Uh Y
    Diagn Microbiol Infect Dis; 2019 May; 94(1):88-92. PubMed ID: 30658867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
    Pfaller MA; Huband MD; Shortridge D; Flamm RK
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China.
    Zhou M; Yang Q; Lomovskaya O; Sun D; Kudinha T; Xu Z; Zhang G; Chen X; Xu Y
    J Antimicrob Chemother; 2018 Oct; 73(10):2789-2796. PubMed ID: 29982437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of aztreonam-avibactam against metallo-β-lactamase-producing Enterobacteriaceae-A multicenter study in China.
    Zhang B; Zhu Z; Jia W; Qu F; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
    Int J Infect Dis; 2020 Aug; 97():11-18. PubMed ID: 32473388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.
    Sader HS; Castanheira M; Shortridge D; Mendes RE; Flamm RK
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.
    Chen A; Smith KP; Whitfield BA; Zucchi PC; Lasco TM; Bias TE; Kirby JE; Hirsch EB
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):365-367. PubMed ID: 28535946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Pfaller MA; Huband MD; Streit JM; Flamm RK; Sader HS
    Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.
    Sader HS; Castanheira M; Huband M; Jones RN; Flamm RK
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.